A detailed history of Founders Capital Management transactions in Medtronic PLC stock. As of the latest transaction made, Founders Capital Management holds 25 shares of MDT stock, worth $2,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 25 -0.0%
Holding current value
$2,267
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025

BUY
$79.84 - $94.5 $1,996 - $2,362
25 New
25 $2,000
Q2 2022

Jul 20, 2022

BUY
$87.4 - $113.09 $5,768 - $7,463
66 Added 29.33%
291 $26,000
Q1 2021

Jun 09, 2021

SELL
$111.18 - $119.74 $25,015 - $26,941
-225 Reduced 50.0%
225 $27,000
Q1 2020

Apr 22, 2020

BUY
$72.92 - $121.3 $16,407 - $27,292
225 Added 100.0%
450 $42,000
Q2 2018

Jul 09, 2018

SELL
$77.48 - $87.83 $148,374 - $168,194
-1,915 Reduced 89.49%
225 $19,000
Q3 2017

Oct 17, 2017

BUY
$77.71 - $84.6 $166,299 - $181,044
2,140
2,140 $166,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $121B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Founders Capital Management Portfolio

Follow Founders Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management with notifications on news.